| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 15 May 2026 | 8 May 2026 |
| Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended 31 March 2026 and to consider the declaration of dividend if any on the equity shares of the Company for the financial year 2025-26. Outcome of Board Meeting today and Financial Results. (As per BSE announcement dated on :15.05.2026) | ||
| Board Meeting | 11 Mar 2026 | 11 Mar 2026 |
| Outcome of Board Meeting and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Divestment of Equity stake in Texas Lifesciences Private Limited, Subsidiary | ||
| Board Meeting | 30 Jan 2026 | 21 Jan 2026 |
| Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and nine months period ended 31 December 2025 | ||
| Board Meeting | 12 Nov 2025 | 4 Nov 2025 |
| Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and six months period ended 30 September 2025. Outcome of Board Meeting held today (As Per BSE Announcement Dated on: 12/11/2025) | ||
| Board Meeting | 1 Aug 2025 | 23 Jul 2025 |
| Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended 30 June 2025. Outcome of Board Meeting held on 1 August 2025 (As Per BSE Announcement Dated on: 01.08.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
